Australia markets closed

Lisata Therapeutics Inc (8NE.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
2.6400+0.2000 (+8.20%)
As of 10:58AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
12,734
12,734
43,460
17,576
9,253
Selling general and administrative
12,974
12,974
14,141
11,474
9,892
Total operating expenses
25,708
25,708
57,601
29,050
19,145
Operating income or loss
-25,708
-25,708
-57,601
-29,050
-19,145
Interest expense
0
-
-
-
-
Total other income/expenses net
2,538
2,538
897
76
132
Income before tax
-23,170
-23,170
-56,704
-28,974
-19,013
Income tax expense
-2,330
-2,330
-2,479
-1,508
-10,872
Income from continuing operations
-20,840
-20,840
-54,225
-27,466
-8,141
Net income
-20,840
-20,840
-54,225
-27,466
-8,150
Net income available to common shareholders
-20,840
-20,840
-54,225
-27,466
-8,150
Basic EPS
-1.11
-
-10.47
-7.45
-7.95
Diluted EPS
-1.11
-
-10.47
-7.45
-7.95
Basic average shares
8,011
-
5,180
3,688
1,029
Diluted average shares
8,011
-
5,180
3,688
1,029